RankingsPricing
  1. US-listed companies
  2. Edwards Lifesciences Corp
  3. Financials
  4. Marketable securities, non-current

Edwards Lifesciences CorpEW

Market cap
$49.7B
P/E ratio
SummaryFinancials
Period EndMarketable securities, non-current (Million USD)YoY (%)
Dec 31, 2024308-47.27%
Dec 31, 2023584-52.87%
Dec 31, 20221,239-32.45%
Dec 31, 20211,834+128.82%
Dec 31, 2020802+36.91%
Dec 31, 2019586+15.64%
Dec 31, 2018506-10.71%
Dec 31, 2017567+6.56%
Dec 31, 2016532+40.06%
Dec 31, 2015380+57.70%
Dec 31, 2014241+1000.00%
Dec 31, 201322+3.79%
Dec 31, 201221-3.21%
Dec 31, 201122-12.80%
Dec 31, 201025

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)